Robert W. Baird set a $71.00 target price on LHC Group (NASDAQ:LHCG) in a report released on Tuesday morning. The firm currently has a hold rating on the health services provider’s stock.

A number of other research analysts have also recently commented on LHCG. Zacks Investment Research upgraded LHC Group from a hold rating to a buy rating and set a $79.00 target price for the company in a research note on Wednesday, November 8th. Royal Bank Of Canada restated a buy rating and issued a $70.00 target price on shares of LHC Group in a research note on Wednesday, September 6th. Bank of America initiated coverage on LHC Group in a research note on Monday, August 21st. They issued a buy rating and a $76.00 target price for the company. BidaskClub upgraded LHC Group from a hold rating to a buy rating in a research note on Friday, August 18th. Finally, Jefferies Group restated a buy rating and issued a $68.00 target price on shares of LHC Group in a research note on Friday, August 4th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $77.10.

Shares of LHC Group (NASDAQ LHCG) traded down $0.74 during mid-day trading on Tuesday, hitting $65.77. The stock had a trading volume of 321,500 shares, compared to its average volume of 145,319. The company has a market cap of $1,220.00, a price-to-earnings ratio of 28.33, a P/E/G ratio of 1.96 and a beta of 0.70. LHC Group has a 12-month low of $41.66 and a 12-month high of $76.14. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.04. The firm had revenue of $272.90 million for the quarter, compared to analyst estimates of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. The business’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same period last year, the company earned $0.54 EPS. research analysts forecast that LHC Group will post 2.4 EPS for the current fiscal year.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the transaction, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.80% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of LHCG. Vanguard Group Inc. grew its holdings in shares of LHC Group by 3.9% in the first quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock worth $77,185,000 after acquiring an additional 54,279 shares during the period. Geode Capital Management LLC grew its holdings in LHC Group by 13.8% during the first quarter. Geode Capital Management LLC now owns 140,971 shares of the health services provider’s stock valued at $7,598,000 after purchasing an additional 17,108 shares during the period. Schwab Charles Investment Management Inc. grew its holdings in LHC Group by 7.0% during the first quarter. Schwab Charles Investment Management Inc. now owns 84,338 shares of the health services provider’s stock valued at $4,546,000 after purchasing an additional 5,551 shares during the period. Bank of America Corp DE grew its holdings in LHC Group by 123.5% during the first quarter. Bank of America Corp DE now owns 34,658 shares of the health services provider’s stock valued at $1,868,000 after purchasing an additional 19,154 shares during the period. Finally, State Street Corp grew its holdings in LHC Group by 4.7% during the first quarter. State Street Corp now owns 391,375 shares of the health services provider’s stock valued at $21,095,000 after purchasing an additional 17,439 shares during the period. Hedge funds and other institutional investors own 85.25% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Robert W. Baird Analysts Give LHC Group (LHCG) a $71.00 Price Target” was published by Daily Political and is owned by of Daily Political. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/12/01/robert-w-baird-analysts-give-lhc-group-lhcg-a-71-00-price-target.html.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.